CGMP-INHIBITED
MOLECULAR TARGETcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A (human)
CGMP-INHIBITED (cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A (human)) is targeted by 21 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting CGMP-INHIBITED
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Cilostazol | 1.39 | 3 |
| 2 | Bucladesine | 1.10 | 2 |
| 3 | Losartan | 0.69 | 1 |
| 4 | Progesterone | 0.69 | 1 |
| 5 | Vitamin K 2 | 0.69 | 1 |
| 6 | Adenosine Triphosphate | 0.69 | 1 |
| 7 | Antazoline | 0.69 | 1 |
| 8 | Aripiprazole | 0.69 | 1 |
| 9 | Cefoperazone Semisynthetic broad-spectrum cephalosporin with | 0.69 | 1 |
| 10 | Clofarabine | 0.69 | 1 |
| 11 | Codeine | 0.69 | 1 |
| 12 | Enoximone | 0.69 | 1 |
| 13 | Gestrinone | 0.69 | 1 |
| 14 | Hexachlorophene | 0.69 | 1 |
| 15 | Irbesartan | 0.69 | 1 |
| 16 | Lamotrigine | 0.69 | 1 |
| 17 | Methicillin | 0.69 | 1 |
| 18 | Nisoldipine | 0.69 | 1 |
| 19 | Papaverine | 0.69 | 1 |
| 20 | Rimonabant | 0.69 | 1 |
| 21 | Troglitazone | 0.69 | 1 |
About CGMP-INHIBITED as a Drug Target
CGMP-INHIBITED (cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A (human)) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 21 compounds with documented CGMP-INHIBITED interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
CGMP-INHIBITED inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.